Skip to main content

Table 1 Baseline Demographic and Clinical Features of the Study Cohort

From: Assessment of left atrioventricular coupling and left atrial function impairment in diabetes with and without hypertension using CMR feature tracking

 

DM-HP

(n = 73)

DM + HP

(n = 103)

P value

Demographics

   

sex, male, n(%)

39(53)

60(58)

0.623

Age, years

57±11

61±11

0.075

BSA, m2

1.65±0.15

1.70±0.20

0.008

Dyslipidemia, n(%)

27(37.0)

42(40.8)

0.716

Current smoking, n(%)

13(17.8)

35(33.9)

0.022

SBP, mmHg

125±14

134±17

< 0.001

DBP, mmHg

78±12

80±12

0.356

Laboratory indices

   

HbA1c (%)

7.34±1.70

7.00±1.22

0.179

TG, mmol/l

2.00±1.77

1.62±1.09

0.075

TC, mmol/l

4.49±1.40

4.05±1.20

0.027

HDL-C, mmol/l

1.21 + 0.34

1.23±0.38

0.718

LDL-C, mmol/l

2.60±1.47

2.31±1.02

0.118

Medications, n (%)

   

ACEI/ARB

12(16.4)

87(84.5)

< 0.001

Beta-blocker

4(5.5)

13(12.6)

< 0.001

Calcium channel blocker

3(4.1)

27(26.2)

< 0.001

Diuretics

5(6.8)

25(24.3)

0.005

anti-diabetic treatment, n (%)

   

insulin

11(15.1)

18(17.5)

0.671

metformin

12(16.4)

21(20.4)

0.508

sulfonylurea

18(24.7)

27(26.3)

0.816

α-glucosidase inhibitor

20(27.4)

24(23.3)

0.536

other

2(2.7)

4(3.9)

0.479

non-drug

13(17.8)

16(15.6)

0.689

  1. Note: Data are presented as mean±SD or number (percentage)
  2. Abbreviations: DM-HP: diabetes without hypertension; DM + HP: diabetes with hypertension; BSA: body surface area; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ACEI/ARB: Angiotensin Converting Enzyme Inhibitor/ Angiotensin Receptor Blocker
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840